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Prognosticating COVID-19:  
A need for Africa-specific laboratory 
predictors
To the Editor: The rapid spread of SARS-CoV-2 throughout the 
world has resulted in significant morbidity and mortality globally. [1] 
As of 18 April 2020, there were over 20 000 COVID-19 infections 
and over 1 000 deaths in Africa, with more cases being diagnosed 
as testing is slowly ramped up.[2] In view of increasing mortality and 
scarce critical care resources, there is a need to evaluate the role of 
routine laboratory tests in determining which COVID-19 patients 
will require critical care and who is likely to survive.
A systematic review by Lippi and Plebani[3] reported that the 
common derangements in laboratory tests seen in COVID-19 
patients include increased white blood cells, neutrophils, lactate 
dehydrogenase (LDH), alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), total bilirubin, creatinine, cardiac troponin, 
D-dimer, prothrombin time, procalcitonin and C-reactive protein 
(CRP), as well as a decrease in lymphocytes and albumin. None of the 
included studies was from Africa.
Wang et al.[4] examined the baseline laboratory parameters on the 
day of admission in 138 Chinese patients with COVID-19. Significant 
differences in median values were noted for several analytes between 
patients who needed intensive care unit (ICU) admission and those 
who did not. Specifically, patients admitted to an ICU had higher 
neutrophils, LDH, ALT, AST, total bilirubin, creatinine, cardiac 
troponin I, D-dimer and procalcitonin.
There are currently no publications from Africa describing the 
prognostic significance of laboratory tests in predicting severity 
of COVID-19, despite evidence that race and ethnicity are known 
sources of variation in reference intervals.[5] Karita et al.[6] carried out 
a cross-sectional study of healthy adults in Kenya, Uganda, Zambia 
and Rwanda from December 2004 to October 2006. Compared with 
the USA, they found that the reference interval lower limits for 
neutrophils and creatinine were lower in Africans, while upper limits 
for total bilirubin, LDH, ALT and AST were higher.[6] Genetic deletion 
of the Duffy antigen receptor for chemokines (DARC-null genotype) 
is thought to be responsible for the benign neutropenia seen in sub-
Saharan Africa.[7] In several African countries, total bilirubin has 
been found to be almost twice the upper limit of that in Caucasians, 
while transaminases have also been found to be elevated. [8-10] Chronic 
inflammation due to infectious or non-infectious causes may explain 
the elevated CRP and IgG levels in sub-Saharan Africa.
In view of racial and ethnic differences in reference values for some 
of the laboratory tests thought to play an important role in COVID-
19 prognosis as well as the huge burden of infectious diseases such 
as HIV, tuberculosis and malaria, there is an urgent need for studies 
that can generate clinical and laboratory data to guide the use of 
laboratory tests in evaluating and managing COVID-19 patients in 
Africa.
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